NASDAQ: CRBPCorbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?
Insider buying vs selling
Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Kenneth Jenkins | Director | 2025-05-30 | 2,783 | $7.35 | $20.47kSell |
| Anne Altmeyer | Director | 2025-05-30 | 1,392 | $7.25 | $10.10kSell |
| Dominic Smethurst | Chief Medical Officer | 2025-03-06 | 6,393 | $6.78 | $43.33kSell |
| Yuval Cohen | Chief Executive Officer | 2025-02-14 | 7,134 | $8.76 | $62.47kSell |
| Sean F. Moran | Chief Financial Officer | 2025-02-14 | 2,792 | $8.76 | $24.45kSell |
| Cormorant Asset Management LP | 10% Owner | 2024-09-20 | 25,943 | $18.36 | $476.31kBuy |
| Cormorant Asset Management LP | 10% Owner | 2024-09-20 | 45,085 | $17.48 | $787.86kBuy |
| Cormorant Asset Management LP | 10% Owner | 2024-09-20 | 25,769 | $22.23 | $572.79kBuy |
| Cormorant Asset Management LP | 10% Owner | 2024-09-20 | 47,564 | $21.47 | $1.02MBuy |
| Cormorant Asset Management LP | 10% Owner | 2024-09-20 | 139,551 | $20.42 | $2.85MBuy |
CRBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRBP insiders and whales buy or sell their stock.
CRBP Shareholders
What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sumner Burstein | 29.38% | 3,594,571 | $31.74M | Insider |
| Cormorant Asset Management LP | 23.02% | 2,817,368 | $24.88M | Insider |
| Knoll Capital Management LP | 22.47% | 2,750,000 | $24.28M | Insider |
| Cormorant Asset Management LP | 19.41% | 2,375,000 | $20.97M | Institution |
| Mark Tepper | 17.25% | 2,110,400 | $18.63M | Insider |
| Orbimed Advisors LLC | 9.58% | 1,172,287 | $10.35M | Institution |
| Octagon Capital Advisors LP | 9.11% | 1,115,000 | $9.85M | Institution |
| Blackrock Inc | 6.91% | 846,062 | $7.47M | Institution |
| David P. Hochman | 6.69% | 818,700 | $7.23M | Insider |
| Vanguard Group Inc | 5.49% | 672,057 | $5.93M | Institution |
CRBP vs Biotech Stocks
Corbus Pharmaceuticals Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.